Remove about leadership
article thumbnail

New pharma CEOs in the hot seat

STAT

Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  A road test for fresh pharma CEOs A lot can change in five years — including the leadership of the three major pharmaceutical companies that will be testifying before Sen. You’re reading the web edition of D.C.

article thumbnail

STAT+: Former medical device CEO who sold dummy, plastic parts convicted of fraud

STAT

Under her leadership, Stimwave distorted the design of the device to better fit insurance codes, resulting in unnecessary plastic components that allowed the company to sell its products for thousands of dollars more than it otherwise could. The maximum jail sentence for each count is 20 years.

291
291
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AlphaFold developers and eye scan inventors among Lasker Award winners for 2023

STAT

The prestigious Lasker Awards for biomedical research are sometimes referred to as “America’s Nobel,” and with good reason — about a fourth of Lasker laureates have gone on to receive the Swedish award, too. Read the rest…

256
256
article thumbnail

STAT+: What happened to the House vote on health care price transparency?

STAT

About last night… House leadership last night canceled a scheduled vote on a health care package that included transparency requirements for hospitals and insurers, reforms to some PBM practices, and a small site-neutral payment policy for administering drugs, Rachel writes. You’re reading the web edition of D.C.

Packaging 239
article thumbnail

STAT+: SEC charges former CEO of pain relief device company with $41 million fraud

STAT

Under her leadership, Stimwave warped the design of the device to better align with insurance codes, resulting in unnecessary plastic components that allowed the company to sell their products for thousands of dollars more than they otherwise could. From 2017 to 2020, the company implanted nearly 8,000 patients with these devices.

278
278
article thumbnail

STAT+: Dewpoint Therapeutics cuts 15% of staff, acknowledges Merck, Pfizer broke off partnerships over buzzy science

STAT

And with funding for early-stage biotechs still sparse, leadership opted to cut some positions and use the savings to fill new ones over the coming months. The company needed to hire new employees with expertise to help move the company’s first drugs into clinical trials and expand its AI capabilities. Roughly 20 positions were cut.

277
277
article thumbnail

STAT+: Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care

STAT

Its goal is to create a system to certify and register AI models, and publish details about their performance before they are widely adopted. It is being formed by a group known as the Coalition for Health AI , whose leadership includes technology experts at the academic hospitals that would host the testing labs.